Chen Min, Yi Fengming, Zhou Feng, Huang Meifang, Li Jin, Yan Wenfeng, Li Lixia, Xia Bing
Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Donghu Road 169, Wuhan, 430071, People's Republic of China,
Surg Today. 2015 Aug;45(8):1002-8. doi: 10.1007/s00595-014-1093-z. Epub 2014 Dec 20.
To establish the risk factors for initial surgery in patients with Crohn's disease (CD) in Central China.
The subjects of this study were patients with CD treated at Zhongnan Hospital of Wuhan University, an IBD center in Wuhan City, Central China, between January, 1992 and June, 2012. We conducted uni- and multivariate analyses of the risk factors for initial surgery for CD in these patients.
A total of 197 patients with CD were included in this study. The cumulative incidence of initial surgery was 21.8, 28.9, and 32.5%, at 1, 5, and 10 years, respectively, after the onset of symptoms. Analysis using multivariate Cox models showed that the relative risk for initial surgery was lower in patients who were younger than 16 years at diagnosis (HR = 0.57, 95% CI 0.34-0.96, P = 0.034). The risk increased in patients with stricturing (HR = 4.75, 95% CI 2.48-9.11), those with CD showing penetrating behavior at diagnosis (HR = 5.14, 95% CI 2.54-10.39), and those with a history of appendectomy (HR = 1.87, 95% CI 1.03-3.40). Azathioprine (AZA) treatment appeared to decrease the risk for initial surgery in patients with non-penetrating and non-stricturing CD (HR = 0.14, 95% CI 0.13-3.10).
Age at diagnosis, disease behavior, and a history of appendectomy appeared to have an impact on the risk for initial surgery. AZA treatment might be helpful for decreasing the risk of needing initial surgery for patients in whom stricturing or fistulizing disease has not yet developed.
确定中国中部地区克罗恩病(CD)患者初次手术的危险因素。
本研究的对象为1992年1月至2012年6月期间在位于中国中部武汉市的武汉大学中南医院IBD中心接受治疗的CD患者。我们对这些患者初次手术的危险因素进行了单因素和多因素分析。
本研究共纳入197例CD患者。症状出现后1年、5年和10年时,初次手术的累积发生率分别为21.8%、28.9%和32.5%。多因素Cox模型分析显示,诊断时年龄小于16岁的患者初次手术的相对风险较低(HR = 0.57,95%CI 0.34 - 0.96,P = 0.034)。狭窄患者(HR = 4.75,95%CI 2.48 - 9.11)、诊断时表现为穿透性病变的CD患者(HR = 5.14,95%CI 2.54 - 10.39)以及有阑尾切除术史的患者(HR = 1.87,95%CI 1.03 - 3.40)风险增加。硫唑嘌呤(AZA)治疗似乎可降低非穿透性和非狭窄性CD患者初次手术的风险(HR = 0.14,95%CI 0.13 - 3.10)。
诊断时的年龄、疾病行为和阑尾切除术史似乎对初次手术风险有影响。对于尚未发生狭窄或瘘管形成疾病的患者,AZA治疗可能有助于降低初次手术的风险。